slide1 l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
3.06. Integrating Compliance with Business: Integrating Compliance Auditing & Monitoring with Internal Audit PowerPoint Presentation
Download Presentation
3.06. Integrating Compliance with Business: Integrating Compliance Auditing & Monitoring with Internal Audit

Loading in 2 Seconds...

play fullscreen
1 / 11

3.06. Integrating Compliance with Business: Integrating Compliance Auditing & Monitoring with Internal Audit - PowerPoint PPT Presentation


  • 127 Views
  • Uploaded on

The Seventh Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum November 9, 2006 Washington, DC. . 3.06. Integrating Compliance with Business: Integrating Compliance Auditing & Monitoring with Internal Audit. Disclaimer.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about '3.06. Integrating Compliance with Business: Integrating Compliance Auditing & Monitoring with Internal Audit' - brinly


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

The Seventh Annual

Pharmaceutical Regulatory and Compliance Congress

and Best Practices Forum

November 9, 2006

Washington, DC.

3.06. Integrating Compliance with Business: Integrating Compliance Auditing & Monitoring with Internal Audit

disclaimer
Disclaimer

The information presented and discussed represents the opinions of the authors/presenters and, although descriptive of general activities, they do not necessarily reflect the views of either Amgen or Deloitte & Touche LLP

outline
Outline
  • Overview of Corporate Compliance and Corporate Audit at Amgen
  • This Session will discuss how Amgen’s Corporate Compliance and Corporate Audit have worked together
  • The presenters will provide insights into
    • The Corporate Compliance Program Structure
    • The Approach that Corporate Compliance and Corporate Audit have taken in defining Role and Responsibilities
wayne davey
Wayne Davey

As Executive Director of Corporate Audit for Amgen, Wayne Davey works with the General Auditor, senior company management, and the audit function staff to provide independent, objective assurance and consulting services designed to add value and improve the operations of Amgen. Upon joining Amgen in June 2004, he became the Project Leader for Amgen’s successful Sarbanes-Oxley compliance and certification efforts. He is currently assigned to lead all worldwide operational and compliance audits.

Prior to his current position at Amgen, Wayne was the CFO and VP of Business Operations at the Rockwell Scientific Company (RSC), a privately-held technology company with approximately $110 million in annual sales. Prior to his position at RSC, he served as Director of Corporate Accounting for Rockwell International and then later in a similar position at Hughes Electronics.

Wayne received a BS degree from the University of Arizona and an MBA degree from UCLA.

david chandler
David Chandler

David Chandler is a Director of Corporate Compliance over the Outcomes and Analysis program at Amgen Inc. His responsibilities include the selection and deployment of a unified audit management system, analysis of audit data within and across audit organizations, and reporting on critical audit findings to executive management.

Prior to his current position he was the Manager of the Compliance and Regulatory program at 3M Pharmaceuticals where his responsibilities included monitoring and developing compliance programs for cGMP, GCP, GLP, HIPAA, Pharmacovigilance, PDMA, WLF, PhRMA Code of Conduct, OIG Guidance, Medical Education, State reporting requirements, and grant and consultant activities. Previous position included Manager of Toxicology at 3M Corporation, Director of the Hazardous Materials Program for the State of Oregon and Principle/Director of the Chemical and Risk Information System and Associate Professor at Oregon Health Sciences University.

David holds a Ph.D. in Pharmacology/Toxicology from the University of California, Davis, and an MBA from the University of St. Thomas.

sheryl vacca
Sheryl Vacca

Sheryl Vacca is the West Coast Practice Leader in the Life Sciences Regulatory Practice at Deloitte & Touche LLP. Sheryl is also the National Lead for Health Care Internal Audit for Deloitte. Sheryl has been in life science for 28 years and has a significant amount of experience in regulatory compliance, auditing and monitoring and dispute areas in life sciences. She has been involved with the development of compliance and operational controls, internal audit and has expertise in providing advice on regulatory compliance issues for life science focusing on internal control process, key risk areas in regulatory compliance, financial and compliance due diligence, operational design and litigation support including voluntary disclosures to enforcement agencies.

Sheryl is a nationally recognized speaker and has published on compliance related topics, including auditing and monitoring concepts, quality of care, compliance program elements and compliance program effectiveness. Ms. Vacca is a Past President and current Board Member of the Health Care Compliance Association. Ms. Vacca has her BSN and also holds a master’s degree in administration. She is also a member of the Editorial Board for the Journal of Health Care Compliance, published by Aspen Publishers.

slide7
Amgen’s Corporate Compliance Model is Based on Embedded Compliance Functions with Centralized Oversight

BoardComplianceCommittee

Corporate ComplianceDepartment

CEOStaff

Structure

Compliance Council

Steering Committees

Embedded Compliance Functions

All Amgen staff members and contractors

Research & Development

Healthcare & Competition

Corporate

Manufacturing & Distribution

Key Compliance Obligations

  • Affirmative Action / EEO
  • Anti-corruption
  • Environmental, Health & Safety
  • Good Records Practices
  • Privacy
  • Validation
  • Good Manufacturing Practices (GMP)
  • Import/Export Controls
  • Good Clinical Practices (GCP)
  • Good Laboratory Practices (GLP)
  • DEA Licensure
  • Animal Research (USDA)
  • Anti-kickback/ Sponsorship Laws
  • Anti-trust/ Competition
  • Drug Safety / Pharmacovigilance
  • Pricing & Reimbursement
  • Promotional Activities
corporate audit has responsibility for general and financial audits

Board of

Board of

Board of

Directors

Directors

Directors

K. Shearer

K. Shearer

K. Sharer

Audit

Audit

Audit

CEO

CEO

CEO

Committee

Committee

Committee

R. Nanula

R. Nanula

CFO

CFO

KPMG

KPMG

KPMG

KPMG

E&Y

E&Y

E&Y

Corporate

Corporate

Audit

Audit

Corporate Audit has Responsibility for General and Financial Audits

Direct link To Senior Managementprovides

• Strategic DirectionforOperational Reviews

• Exposure&Development Opportunities

Direct link to Audit Committee provides

• Independencefor Financial Reviews

corporate audit has responsibility for general and financial audits consulting and investigations
Corporate Audit has Responsibility for General and Financial Audits, Consulting and Investigations
  • Audit Plan developed from an assessment or management request
  • Broad scope designed to provide assurance as to the internal control environment
  • Results shared with Sr. management, Audit Committee and E&Y
  • Examples:
    • Financial reporting / Sarbanes Oxley
    • Information Systems
    • 3rd Party Vendors

Audits

  • Management requests
  • Controls designed and new system/processes
  • Memo’s issued; no ratings given
  • Examples:
    • Push-to-Purchase
    • SOX
    • ERP

Consulting

  • Narrowly focused
  • Conducted in response to specific allegations
  • Results may be shared with management

Investigations

slide10

For Selected Compliance Audits Where Corporate Audit Will Be Conducting the Audit the Following Roles and Responsibilities Have Been Determined